Celgene invests in Anokion; holds option to acquire
Autoimmune disease therapeutics firm Anokion SA and Celgene Corp. (through its Celgene Switzerland LLC division) entered into a collaboration that could result in Celgene buying the smaller biotech.
- Drug Delivery
- Gene Therapy, Cell Therapy
- Large Molecule
- Includes Equity
- Includes M&A Option
- Intra-Biotech Deal
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.